LanzaTech Global, Inc.

LNZA ·Basic Materials, Chemicals, United States
Analysis › Moat Score

Moat Score — LanzaTech Global, Inc.

Total Moat Score 12 / 30
Moat Factor Score Analysis
Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. 4 / 5 LanzaTech's proprietary C. autoethanogenum biocatalyst and nearly two decades of gas fermentation process engineering represent genuine, hard-to-replicate biological IP, proven across six commercial plants. It falls short of a 5 because the technology is still in early commercial scale-up and faces credible alternative-pathway competitors.
Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. 1 / 5 LanzaTech is not a low-cost producer; it remains deeply loss-making with a $49.0 million 2025 net loss and depends on partner capital to build plants rather than owning low-cost scale infrastructure itself.
Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. 1 / 5 With one customer representing 37% of 2025 revenue and ongoing going-concern doubt, LanzaTech has limited leverage to set pricing and instead negotiates from a position of needing partner commitments and government grants to fund operations.
Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. 1 / 5 There is only a minimal network effect: more licensed plants generate more operating data that can refine the biocatalyst and engineering playbook, but LanzaTech lacks any user- or platform-driven network dynamic.
Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. 3 / 5 Once an industrial partner has built a plant around LanzaTech's biocatalyst and process design (often a multi-hundred-million-dollar capital investment), switching to an alternative technology provider would require re-engineering the facility, creating real switching costs for existing licensees.
Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. 2 / 5 LanzaTech is an early mover in commercial-scale gas fermentation, but the addressable market for waste-gas-to-fuel conversion is still nascent and not yet large enough, nor is LanzaTech's share of it clearly dominant enough, to call this an efficient-scale moat today.